Delivery Order SPE2DB24D9230-SPE2DB25FHVPM

Award Date 2/10/25
Potential Completion Date 3/4/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,670.13, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a delivery order under the DLA's SPE2DB program, a $499,999,999 Indefinite Delivery Contract (IDC) valid through November 2026. The delivery order is for the supply of YF-VAX 1 dose vials, a pharmaceutical product. As a key supplier in the federal pharmaceutical supply chain, DMS...
This federal contract award, valued at $1,690.47, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of YF-VAX 1 dose vials, which are likely a specialized vaccine or pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,690.47 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,126.98 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials, a specialized pharmaceutical product. This award falls under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which enables the agency to issue delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $1,113.42, is a firm fixed-price delivery order for YF-VAX 1 dose vials. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue delivery orders for a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,817.45 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $3,380.94, is for the delivery of YF-VAX 1 dose vials, a specialized pharmaceutical product. The contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure this direct...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,094.62 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials, with a period of performance through December 20, 2023. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 with DLA, valid through November 2026. The delivery order, valued at $1,690.47, is for the provision of YF-VAX 1 dose vials, a specialized pharmaceutical product. The IDC enables...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $34,584.00 delivery order for YF-VAX 1 dose vials, with a firm fixed-price pricing type and an ultimate completion date of September 16, 2021. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract...
  • SPE2DB24D9230
    Indefinite Delivery Contract
  • SPE2DB24D9230-SPE2DB25FHVPM
    Delivery Order

This federal contract award is a delivery order valued at $1,113.42 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of YF-VAX 1 dose vials, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities.

The contract is not associated with any set-aside designations, which allows DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure this direct federal award. Additionally, DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.

Generated 5/12/25, 10:47 AM